We just received data on a new analyst forecast for $REPL. Cantor Fitzgerald gave a rating of 'Overweight' for $REPL.
$REPL Analyst Ratings
Wall Street analysts have issued reports on $REPL in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 07/30/2025
- BMO Capital issued a "Underperform" rating on 07/23/2025
- Jefferies issued a "Buy" rating on 07/22/2025
- Piper Sandler issued a "Overweight" rating on 06/02/2025
To track analyst ratings and price targets for $REPL, check out Quiver Quantitative's $REPL forecast page.
$REPL Price Targets
Multiple analysts have issued price targets for $REPL recently. We have seen 8 analysts offer price targets for $REPL in the last 6 months, with a median target of $5.0.
Here are some recent targets:
- Evan David Seigerman from BMO Capital set a target price of $2.0 on 07/23/2025
- Peter Lawson from Barclays set a target price of $3.0 on 07/23/2025
- Jonathan Chang from Leerink Partners set a target price of $3.0 on 07/22/2025
- Anupam Rama from JP Morgan set a target price of $9.0 on 07/22/2025
- Roger Song from Jefferies set a target price of $6.0 on 07/22/2025
- Robert Driscoll from Wedbush set a target price of $4.0 on 07/22/2025
- Robert Burns from HC Wainwright & Co. set a target price of $22.0 on 07/03/2025
$REPL Insider Trading Activity
$REPL insiders have traded $REPL stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $REPL stock by insiders over the last 6 months:
- PHILIP ASTLEY-SPARKE sold 32,279 shares for an estimated $260,168
- SUSHIL PATEL (Chief Executive Officer) sold 25,105 shares for an estimated $202,346
- KONSTANTINOS XYNOS (Chief Medical Officer) sold 7,952 shares for an estimated $64,093
- CHRISTOPHER SARCHI (Chief Commercial Officer) sold 3,749 shares for an estimated $30,179
- ANDREW SCHWENDENMAN (Chief Accounting Officer) sold 3,287 shares for an estimated $26,460
- EMILY LUISA HILL (Chief Financial Officer) sold 2,535 shares for an estimated $20,406
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$REPL Hedge Fund Activity
We have seen 80 institutional investors add shares of $REPL stock to their portfolio, and 65 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MARSHALL WACE, LLP added 1,591,501 shares (+177.6%) to their portfolio in Q1 2025, for an estimated $15,517,134
- SOFINNOVA INVESTMENTS, INC. removed 669,583 shares (-21.3%) from their portfolio in Q1 2025, for an estimated $6,528,434
- ROSALIND ADVISORS, INC. added 590,000 shares (+226.9%) to their portfolio in Q1 2025, for an estimated $5,752,500
- BLACKROCK, INC. added 495,498 shares (+8.9%) to their portfolio in Q1 2025, for an estimated $4,831,105
- CATALIO CAPITAL MANAGEMENT, LP added 355,640 shares (+inf%) to their portfolio in Q1 2025, for an estimated $3,467,490
- BANK OF AMERICA CORP /DE/ added 336,854 shares (+1379.2%) to their portfolio in Q1 2025, for an estimated $3,284,326
- BALYASNY ASSET MANAGEMENT L.P. added 333,237 shares (+inf%) to their portfolio in Q1 2025, for an estimated $3,249,060
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
